re: Ann: Intention to redomicile - supplement... Yes I undertsand that the new CEO is from Goldman Sachs. What I am referring to is the companies refusal to go down the path of standard financing and instead look for the "perfect" deal. Expectations are obviously set too high after the last deal and are stalling the company. This is probably why they have hired a financing expert -all they seem to be worried about is getting an unrealistic financing deal instead of getting the bloody thing started before zirconium supply catches back up. ATR have been based in
China before without needing to list there. They've got so much cash and they got Donald for a song. Looks like they are trying to pull off another wonder deal but it just looks too unlikely. As Kerry Packer said “You only get one Allan Bond in your lifetime and I've already had mine.”
- Forums
- ASX - By Stock
- ATR
- Ann: Intention to redomicile - supplementary anno
ATR
astron corporation limited
Add to My Watchlist
1.72%
!
57.0¢

Ann: Intention to redomicile - supplementary anno, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
57.0¢ |
Change
-0.010(1.72%) |
Mkt cap ! $119.2M |
Open | High | Low | Value | Volume |
57.5¢ | 57.5¢ | 57.0¢ | $8.605K | 14.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 38700 | 56.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
57.5¢ | 23136 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 38700 | 0.560 |
3 | 34072 | 0.550 |
1 | 20000 | 0.545 |
1 | 8000 | 0.510 |
1 | 19980 | 0.500 |
Price($) | Vol. | No. |
---|---|---|
0.575 | 23136 | 1 |
0.610 | 19000 | 1 |
0.630 | 9112 | 1 |
0.700 | 25488 | 3 |
0.740 | 10000 | 1 |
Last trade - 12.33pm 04/07/2025 (20 minute delay) ? |
Featured News
ATR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online